• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Manage my Subscription
  • 日本語
    • 化学工業日報
    • 広告掲載について

Asahi Kasei Medical to Enter Pharmaceutical CDMO Business

Apr. 22, 2022

Filed Under: Pharma Tagged With: acquisitions, asahi kasei, Asahi Kasei Medical, Bionova Scientific, biopharmaceuticals, CDMO, M&A, pharmaceutical

Asahi Kasei Medical Co. Ltd. recently announced that it will acquire California-based Bionova Scientific LLC, a CDMO for biopharmaceuticals. The…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Targets Sales of 1 Trillion Yen in Health Care Sector
Asahi Kasei Targets Sales of 1 Trillion Yen in Health Care…
Asahi Kasei Targets US Market in Bid to Become Global Health Care Company
Asahi Kasei Targets US Market in Bid to Become Global Health…
Mitsui Chemicals to Acquire Asahi Kasei's Pellicle Business for 7.4B Yen
Mitsui Chemicals to Acquire Asahi Kasei's Pellicle Business…
Asahi Kasei Leans on Zoll Acquisition to Accelerate Growth in Health Care Sector
Asahi Kasei Leans on Zoll Acquisition to Accelerate Growth…
Asahi Kasei to Commercialize Plant-Based Polyamide 66
Asahi Kasei to Commercialize Plant-Based Polyamide 66
Asahi Kasei Grows Worldwide Business for CO2 Chemicals – Part 2: Innovations to PC Resin Production
Asahi Kasei Grows Worldwide Business for CO2 Chemicals –…
Previous Post: « New Law Marks 2022 as First Year of a Circular Economy in Japan – Part 7
Next Post: Mitsubishi Heavy Industries to Launch Carbon Capture Service for Small to Medium Emitters »

Primary Sidebar

Latest Articles

Sumco Considers Further Expansion to Deal With Demand From 2027 Onward

Jun. 30, 2022

Ube Sees Starch-Based PA Adopted in Europe

Jun. 30, 2022

Arkema Lines up Asian Boost to Production Capacity for Bio-Based PA

Jun. 30, 2022

Mitsui Chemicals Looks to Enter Sepsis Diagnostics Market

Jun. 30, 2022

AGC Aims to Expand Agrochemical CDMO Business by Developing Active Ingredients to Rival China

Jun. 30, 2022

Most Popular

  • Mitsubishi Pencil to Launch CNT Dispersant for LiBs by 2023
  • Sumco Considers Further Expansion to Deal With Demand From 2027 Onward
  • Zeon Targets Automotive Sector With Adhesives for Heterogeneous Bonding
  • Interview: Cytiva CEO Emmanuel Ligner Discusses Booming Business, Future Plans
  • Toray Launches New Unit to Combine Automotive & Environmental Materials

Tags

asahi kasei Automotive automotive materials batteries china CO2 CO2 emissions coronavirus electric vehicles environment ethylene EV health care industry trends interview investments LiB LiB materials M&A market conditions medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new facilities new materials petrochemical pharmaceutical polypropylene production production increase R&D recycling semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2023 · Chemical Daily v2 on Genesis Framework · WordPress · Log in